# A Study of the Effects of Oxytocin in Adults With Binge-eating Disorder

> **NCT05664516** · PHASE2 · RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Binge-eating Disorder

## Interventions

- **DRUG:** TNX-1900 (Tonix Pharmaceuticals)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05664516
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-03-07
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05664516

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05664516, "A Study of the Effects of Oxytocin in Adults With Binge-eating Disorder". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05664516. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*